Carisoprodol Tablet
Product Images NDC 52536-682

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 52536-682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wilshire Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carisoprodol 01)

Chemical structure diagram of Carisoprodol, displaying its molecular arrangement with labeled atoms and bonds for this active pharmaceutical ingredient.*

FDA Label Image

Principal Display Panel (250 mg Tablet Bottle Label)

Carisoprodol 250 mg tablet label from Wilshire Pharmaceuticals, Inc. The label displays the NDC 52536-682-10 and indicates this is a prescription drug with 100 tablets per container. Key information includes dosage strength (250 mg), storage instructions, and a note on child-resistant packaging. Manufacturer details show Wilshire Pharmaceuticals, Atlanta, GA, with a product origin noted as India.*

FDA Label Image

Principal Display Panel (350 mg Tablet Bottle Label)

Label for Carisoprodol 350 mg oral tablets by Wilshire Pharmaceuticals, Inc. The label indicates the strength as 350 mg per tablet and includes a count of 100 tablets. It shows the prescription-only status and includes storage instructions, packaging requirements, and a barcode with a QR code. The label also states the product is manufactured for Wilshire Pharmaceuticals, Inc. in Atlanta, GA, and is a product of India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.